| Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins J Greeve, I Altkemper, JH Dieterich, H Greten, E Windler Journal of lipid research 34 (8), 1367-1383, 1993 | 363 | 1993 |
| The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress I Greeve, I Hermans-Borgmeyer, C Brellinger, D Kasper, T Gomez-Isla, ... Journal of Neuroscience 20 (19), 7345-7352, 2000 | 357 | 2000 |
| Age-dependent neurodegeneration and Alzheimer-amyloid plaque formation in transgenic Drosophila I Greeve, D Kretzschmar, JA Tschäpe, A Beyn, C Brellinger, M Schweizer, ... Journal of Neuroscience 24 (16), 3899-3906, 2004 | 353 | 2004 |
| Interferon‐inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication M Bonvin, F Achermann, I Greeve, D Stroka, A Keogh, D Inderbitzin, ... Hepatology 43 (6), 1364-1374, 2006 | 313 | 2006 |
| DHCR24 gene expression is upregulated in melanoma metastases and associated to resistance to oxidative stress‐induced apoptosis D Di Stasi, V Vallacchi, V Campi, T Ranzani, M Daniotti, E Chiodini, ... International journal of cancer 115 (2), 224-230, 2005 | 105 | 2005 |
| Neuronal differentiation of human mesenchymal stem cells: changes in the expression of the Alzheimer's disease-related gene seladin-1 S Benvenuti, R Saccardi, P Luciani, S Urbani, C Deledda, I Cellai, ... Experimental cell research 312 (13), 2592-2604, 2006 | 87 | 2006 |
| Acute partial transverse myelitis: risk factors for conversion to multiple sclerosis J Sellner, N Lüthi, R Bühler, A Gebhardt, O Findling, I Greeve, HP Mattle European journal of neurology 15 (4), 398-405, 2008 | 80 | 2008 |
| Adaptation of neuronal cells to chronic oxidative stress is associated with altered cholesterol and sphingolipid homeostasis and lysosomal function AB Clement, M Gamerdinger, IY Tamboli, D Lütjohann, J Walter, I Greeve, ... Journal of neurochemistry 111 (3), 669-682, 2009 | 59 | 2009 |
| Expression of the novel adrenocorticotropin-responsive gene selective Alzheimer’s disease indicator-1 in the normal adrenal cortex and in adrenocortical adenomas and carcinomas P Luciani, P Ferruzzi, G Arnaldi, C Crescioli, S Benvenuti, G Nesi, A Valeri, ... The Journal of Clinical Endocrinology & Metabolism 89 (3), 1332-1339, 2004 | 55 | 2004 |
| Effect of interferon-β and atorvastatin on Th1/Th2 cytokines in multiple sclerosis J Sellner, I Greeve, O Findling, CP Kamm, C Minten, B Engelhardt, ... Neurochemistry international 53 (1-2), 17-21, 2008 | 38 | 2008 |
| Anti‐myelin antibodies in clinically isolated syndrome indicate the risk of multiple sclerosis in a Swiss cohort I Greeve, J Sellner, T Lauterburg, U Walker, KM Rösler, HP Mattle Acta neurologica scandinavica 116 (4), 207-210, 2007 | 22 | 2007 |
| Atorvastatin decreases high-sensitivity C-reactive protein in multiple sclerosis J Sellner, I Greeve, HP Mattle Multiple Sclerosis Journal 14 (7), 981-984, 2008 | 20 | 2008 |
| Uric acid and multiple sclerosis HP Mattle, C Lienert, I Greeve Therapeutische Umschau. Revue Therapeutique 61 (9), 553-555, 2004 | 15 | 2004 |
| Atorvastatin does not alter serum levels of sCD95 and sCD95L in multiple sclerosis J Sellner, I Greeve, O Findling, D Grandgirard, SL Leib, HP Mattle Clinical & Experimental Immunology 152 (2), 280-284, 2008 | 8 | 2008 |
| Atorvastatin Does Not Alter Interferon Beta–Induced Changes of Serum Matrix Metalloproteinase 9 and Tissue Inhibitor of Metalloproteinase 1 in Patients With Multiple Sclerosis J Sellner, I Greeve, SL Leib, HP Mattle Archives of neurology 65 (5), 672-677, 2008 | 6 | 2008 |
| Methods of diagnosing or treating neurological diseases and cell degeneration R Nitsch, I Greeve US Patent App. 10/910,772, 2005 | 6 | 2005 |
| Antimyelin antibodies as predictors of disability after clinically isolated syndrome O Findling, I Durot, A Weck, S Jung, CP Kamm, I Greeve, HP Mattle, ... International Journal of Neuroscience 124 (8), 567-572, 2014 | 4 | 2014 |
| Effects of immunomodulatory treatment in multiple sclerosis on the transendothelial migration of T-cells across the blood-brain barrier I Greeve, J Sellner, C Minten, O Steiner, M Meier, T Lauterburg, U Walker, ... | 1 | 2009 |
| The combination of interferon-beta and atorvastatin lowers high-sensitivity C-reactive protein in multiple sclerosis J Sellner, I Greeve, CP Kamm, HP Mattle EUROPEAN JOURNAL OF NEUROLOGY 17, 220-220, 2010 | | 2010 |
| Atorvastatin does not interfere with interferon-beta induced alterations of soluble CD95/CD95L serum levels in multiple sclerosis: results from the Swiss Atorvastatin and … J Sellner, I Greeve, O Findling, D Grandgirard, SL Leib, HP Mattle | | 2009 |
